| Naslov: | Advancing allogeneic hematopoietic stem cell transplantation outcomes through immunotherapy : a comprehensive review of optimizing non-CAR donor T-lymphocyte infusion strategies |
|---|
| Avtorji: | ID Braidotti, Stefania (Avtor)
ID Granzotto, Marilena (Avtor)
ID Curci, Debora (Avtor)
ID Faganel Kotnik, Barbara (Avtor)
ID Maximova, Natalia (Avtor) |
|---|
| Datoteke: |  PDF - Predstavitvena datoteka, prenos (329,61 KB)
MD5: C731806337BA5C30562FA4349AB37788
 URL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2227-9059/12/8/1853
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.02 - Pregledni znanstveni članek |
|---|
| Organizacija: |  UKC LJ - Univerzitetni klinični center Ljubljana
|
|---|
| Povzetek: | Optimized use of prophylactic or therapeutic donor lymphocyte infusions (DLI) is aimed at improving clinical outcomes in patients with malignant and non-malignant hematological diseases who have undergone allogeneic hematopoietic stem cell transplantation (allo-HSCT). Memory Tlymphocytes (CD45RA−/CD45RO+) play a crucial role in immune reconstitution post-HSCT. The infusion of memory T cells is proven to be safe and effective in improving outcomes due to the enhanced reconstitution of immunity and increased protection against viremia, without exacerbating graft-versus-host disease (GVHD) risks. Studies indicate their persistence and efficacy in combating viral pathogens, suggesting a viable therapeutic avenue for patients. Conversely, using virus-specific T cells for viremia control presents challenges, such as regulatory hurdles, cost, and production time compared to CD45RA-memory T lymphocytes. Additionally, the modulation of regulatory T cells (Tregs) for therapeutic use has become an important area of investigation in GVHD, playing a pivotal role in immune tolerance modulation, potentially mitigating GVHD and reducing pharmacological immunosuppression requirements. Finally, donor T cell-mediated graft-versus-leukemia immune responses hold promise in curbing relapse rates post-HSCT, providing a multifaceted approach to therapeutic intervention in high-risk disease scenarios. This comprehensive review underscores the multifaceted roles of T lymphocytes in HSCT outcomes and identifies avenues for further research and clinical application |
|---|
| Ključne besede: | hematopoietic stem cell transplantation, T lymphocyte, memory T cells, virus-specific T cells, graft-versus-host disease, graft-versus-leukemia |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Leto izida: | 2024 |
|---|
| Št. strani: | str. 1-19 |
|---|
| Številčenje: | Vol. 12, iss. 8, [article no.] 1853 |
|---|
| PID: | 20.500.12556/DiRROS-27873  |
|---|
| UDK: | 61 |
|---|
| ISSN pri članku: | 2227-9059 |
|---|
| DOI: | 10.3390/biomedicines12081853 |
|---|
| COBISS.SI-ID: | 229915139 |
|---|
| Opomba: | Nasl. z nasl. zaslona;
Opis vira z dne 23. 3. 2025;
|
|---|
| Datum objave v DiRROS: | 26.02.2026 |
|---|
| Število ogledov: | 157 |
|---|
| Število prenosov: | 57 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
